Advertisement
Advertisement
SABS
SAB Biotherapeutics, Inc. Common Stock
3.39
USDSponsored
-0.11
-3.14%
Sep 23, 16:00 UTC -4
Closed
After-Market
3.37
-0.02
-0.62%
SAB Biotherapeutics, Inc. Common Stock Financial Snapshot
| Market Cap | 306.53M |
| Beta | 0.53 |
| Earnings Per Share (EPS) | -1.30 |
| Price-to-Book (P/B) Ratio | 1.21 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 1.49% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -6.74% |
| Current Ratio | 9.22% |
| Free Cash Flow | -26.68M |
